Effect of omega-3 fatty acid supplementation on cancer incidence, non-vascular death, and total mortality: A meta-analysis of randomized controlled trials

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Zhang, Yu Fei ^a   Gao, Hong Fang ^a   Hou, An Ji ^a   Zhou, Yu Hao ^a  

^a SHANGHAI SEVENTH PEOPLE S HOSPITAL   (China)

Author keywords

Cancer; Meta analysis; Mortality; Omega 3 fatty acid

Indexed keywords

OMEGA 3 FATTY ACID;

DIET SUPPLEMENTATION; HUMAN; INCIDENCE; META ANALYSIS; MORTALITY; NEOPLASMS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS; INCIDENCE; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84897617527     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-204     Document Type: Article

References (38)

1. Prospective study of diet and female colorectal cancer: the New York University Women's Health Study. Kato I, Akhmedkhanov A, Koenig K, Toniolo PG, Shore RE, Nutr Cancer 1997 28 276 281 10.1080/01635589709514588 9343837
2. Diet and lung cancer risk from a 14-year population-based prospective study in Japan: with special reference to fish consumption. Takezaki T, Inoue M, Kataoka H, Ikeda S, Yoshida M, Nutr Cancer 2003 45 160 167 10.1207/ S15327914NC4502-04 12881009
3. No association between fat and fatty acids intake and risk of colorectal cancer. Terry P, Bergkvist L, Holmberg L, Wolk A, Cancer Epidemiol Biomarkers Prev 2001 10 913 914 11489762
4. Omega-3 fatty acids can improve radioresponse modifying tumor interstitial pressure, blood rheology and membrane peroxidability. Baronzio G, Freitas I, Griffini P, Bertone V, Pacini F, Anticancer Res 1994 14 1145 1154 8074465
5. Role of n-3 polyunsaturated fatty acids (PUFA) in autoimmunity, inflammation, carcinogenesis, and apoptosis. Avula CPR, Lawrence RA, Jolly CA, Fernandes G, Recent Res Develop Lipids 2000 4 303 319
6. Anticarcinogenic effects of diet related apoptosis in the colorectal mucosa. Johnson IT, Food Chem Toxicol 2002 40 1171 1178 10.1016/S0278-6915(02) 00051-0 12067580
7. Absence of prophylactic effect of linolenic acid in patients with coronary heart-disease. Borchgrevink CF, Skaga E, Berg KJ, Skjaeggestad O, Lancet 1966 2 187 189 4161161
8. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Lancet 1989 2 757 761 2571009
9. Fish oil in diabetic nephropathy. Rossing P, Hansen BV, Nielsen FS, Myrup B, Holmer G, Diabetes Care 1996 19 1214 1219 10.2337/diacare.19.11.1214 8908382
10. The effect of dietary omega-3 fatty acids on coronary atherosclerosis: a randomized, double-blind, placebo-controlled trial. von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H, Ann Intern Med 1999 130 554 562 10.7326/0003-4819-130-7-199904060-00003 10189324
11. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. GISSI-Prevenzione Investigators, Lancet 1999 354 447 455 10465168
12. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Nilsen DW, Albrektsen G, Landmark K, Moen S, Aarsland T, Am J Clin Nutr 2001 74 50 56 11451717
13. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Eur J Clin Nutr 2003 57 193 200 10.1038/sj.ejcn.1601539 12571649
14. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators. A randomized controlled trial. Raitt MH, Connor WE, Morris C, Kron J, Halperin B, JAMA 2005 293 2884 2891 10.1001/jama.293.23.2884 15956633
15. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the study on omega-3 fatty acids and ventricular arrhythmia (SOFA) randomized trial. Brouwer IA, Zock PL, Camm AJ, Bocker D, Hauer RN, JAMA 2006 295 2613 2619 16772624
16. Eff ects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis. Japan EPA lipid intervention study (JELIS) Investigators, Lancet 2007 369 1090 1098 10.1016/S0140-6736(07)60527-3 17398308
17. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. SU.FOL.OM3 Collaborative Group, BMJ 2010 341 6273 10.1136/bmj.c6273 21115589
18. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group, Plos Medicine 2009 6 1000097 10.1371/journal.pmed.1000097 19621072
19. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Jadad AR, Moore RA, Carroll D, Control Clin Trials 1996 17 1 12 10.1016/0197-2456(95)00134-4 8721797
20. Meta-analysis in clinical trials. DerSimonian R, Laird N, Control Clin Trials 1986 7 177 188 10.1016/0197-2456(86)90046-2 3802833
21. The interpretation of random-effects metaanalysis in decision models. Ades AE, Lu G, Higgins JP, Med Decis Making 2005 25 646 654 10.1177/ 0272989X05282643 16282215
22. Analyzing data and undertaking meta-analyses. Deeks JJ, Higgins JPT, Altman DG, Cochrane Handbook for Systematic Reviews of Interventions 5.0.1 Oxford, UK: The Cochrane Collaboration: chap 9, Higgins J, Green S, 2008
23. Measuring inconsistency in meta-analyses. Higgins JPT, Thompson SG, Deeks JJ, Altman DG, BMJ 2003 327 557 560 10.1136/bmj.327.7414.557 12958120
24. How should meta-regression analyses be undertaken and interpreted? Thompson SG, Higgins JP, Stat Med 2002 21 1559 1573 10.1002/sim.1187 12111920
25. Interaction revisited: the difference between two estimates. Altman DG, Bland JM, BMJ 2003 326 219 10.1136/bmj.326.7382.219 12543843
26. Bias in meta-analysis detected by a simple, graphical test. Egger M, Davey Smith G, Schneider M, Minder C, BMJ 1997 315 629 634 10.1136/bmj.315.7109. 629 9310563
27. Operating characteristics of a rank correlation test for publication bias. Begg CB, Mazumdar M, Biometrics 1994 50 1088 1101 10.2307/2533446 7786990
28. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. de Lorgeril M, Renaud S, Mamelle N, Sslen P, Martin JL, Lancet 1994 343 1454 1459 10.1016/S0140-6736(94)92580-1 7911176
29. Randomized controlled trial of gamma-linolenic acid eicosapentaenoic acid in peripheral arterial disease. Leng GC, Lee AJ, Fowkes FG, Jepson RG, Lowe GD, Clin Nutr 1998 17 265 271 10.1016/S0261-5614(98)80318-X 10205349
30. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Circulation 2005 112 2762 2768 10.1161/CIRCULATIONAHA.105.549527 16267249
31. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. GISSI-HF investigators, Lancet 2008 372 1223 1230 10.1016/S0140-6736(08) 61239-8 18757090
32. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. OMEGA Study Group, Circulation 2010 122 2152 2159 10.1161/CIRCULATIONAHA.110.948562 21060071
33. A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk. Einvik G, Klemsdal TO, Sandvik L, Hjerkinn EM, Eur J Cardiovasc Prev Rehabil 2010 17 588 592 10.1097/HJR.0b013e328339cc70 20389249
34. n-3 fatty acids and cardiovascular events after myocardial infarction. Alpha Omega Trial Group, N Engl J Med 2010 363 2015 26 10.1056/NEJMoa1003603 20929341
35. Trial investigators: n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. The ORIGIN, N Engl J Med 2012 367 309 318 22686415
36. Effects of omega-3 fatty acids on cancer risk a systematic review. MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, JAMA 2006 295 403 415 10.1001/jama.295.4.403 16434631
37. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Bartsch H, Nair J, Owen RW, Carcinogenesis 1999 20 2209 2218 10.1093/carcin/20.12.2209 10590211
38. Effect of fish oil on arrhythmias and mortality: systematic review. Leon H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, BMJ 2009 338 2931